Skip to main content
Caplight Logo









Chronos DX

Chronos DX

Private
LondonHealthcare & Life Scienceshttps://chronosdx.co.uk

Last Round

Pre Seed

Sep 30, 2022

Company Overview

Chronos DX operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Pre Seed round in September 2022.

Chronos DX is a biotechnology company that develops high-performance, scalable bioassay technology for early disease detection, drug screening, and biomarker monitoring.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Sensors, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Chronos DX Comparables

Compare Chronos DX with similar companies based on industry and business-model similarity.

Chronos DX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proteins.1
86%
Primary Bioscience
81%
Erisyon
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Chronos DX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 30, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Chronos DX Investors

Notable investors and investment history

Chronos DX investors
InvestorRounds
Science Entrepreneur ClubPre Seed
New Jersey Economic Development AuthorityPre Seed
Entrepreneurs FirstPre Seed
SOSVPre Seed
HAXPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 30, 2022

    Secured funding from SOSV, Entrepreneurs First, and HAX.

Book a demo to see all signals

For institutional investors. Book with your work email.

Chronos DX Filings

Explore SEC and related filing metadata, where available.

Chronos DX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Chronos DX's valuation, stock price, and market status.

Is Chronos DX a public or private company?

Chronos DX is a private company.

What is the current stock price of Chronos DX?

Chronos DX is a private company, so its shares have no public market price. Caplight tracks Chronos DX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Chronos DX worth (valuation)?

Valuation information for Chronos DX is not publicly available.

Can I buy Chronos DX stock?

Chronos DX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Chronos DX's last funding round?

Chronos DX's most recent funding round was Pre Seed on September 30, 2022.

Who are the main investors in Chronos DX?

Key investors in Chronos DX include Science Entrepreneur Club, New Jersey Economic Development Authority, Entrepreneurs First, SOSV, HAX.

Will Chronos DX IPO soon?

No public IPO plans have been announced for Chronos DX.

How can I track Chronos DX secondary market activity?

Caplight tracks bids, offers, and trades in Chronos DX's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Year Founded2022
Last FundingSep 30, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?